Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 26, 2015 4:43 PM ET

Company Overview of Albert Einstein College of Medicine

Company Overview

Albert Einstein College of Medicine is an educational institution.

1300 Morris Park Avenue

Jack and Pearl Resnick Campus

Bronx, NY 10461

United States

Founded in 1984



Key Executives for Albert Einstein College of Medicine

Professor and Chairman of the Department of Cardiothoracic Surgery
Compensation as of Fiscal Year 2015.

Albert Einstein College of Medicine Key Developments

Albert Einstein College of Medicine Wins $1,999,645 Federal Contract

Albert Einstein College of Medicine won a $1,999,645 federal contract from the U.S. Health and Human Services Department's National Institutes of Health, Rockville, Maryland, to conduct a definitive randomized clinical trial of carbon ion radiotherapy versus 3D conformal radiation therapy for locally and advanced unresectable pancreatic cancer.

Actinium Announces Collaboration with Albert Einstein College of Medicine on New Actinium Program

Actinium Pharmaceuticals, Inc. announced collaboration with Albert Einstein College of Medicine on New Actinium Program. The company and Albert Einstein College of Medicine of Yeshiva University started development of an antibody construct labeled with actinium-225 using a novel technology that potentially allows for the expansion of use of the Company's proprietary platform and enables further manufacturing improvements of alpha therapy technology based drug candidates. The first antibody to be labeled using the new technology has potential to be broadly used in the field of hematology/oncology. Preclinical studies of the new technology have demonstrated significant improvements in product's manufacturing while maintaining biological integrity and properties of labeled antibodies. In addition to making the manufacturing process more time and cost efficient, the new technology allows for a greater versatility in adjusting the final constructs to various clinical situations. Clinical trials of drug candidates based on alpha emitting isotopes have already demonstrated significant efficacy with minimal side effects in blood borne cancers, in metastases of solid cancers and in residual disease in solid cancers post-surgery.

The Children's Hospital at Montefiore and Albert Einstein College of Medicine Appoints Betsy Herold as Chief of the Division of Pediatric Infectious Diseases

The Children’s Hospital at Montefiore (CHAM) and Albert Einstein College of Medicine of Yeshiva University have named Betsy Herold, M.D., chief, Division of Pediatric Infectious Diseases, CHAM and Einstein. She assumed her new position on July 1. Dr. Herold also serves as vice chair for research development in the Department of Pediatrics at CHAM and Einstein. She is a professor of Pediatrics, Microbiology and Immunology, and Obstetrics & Gynecology and Women’s Health and holds the Harold and Muriel Block Chair of Pediatrics at Einstein. Dr. Herold joined Montefiore and Einstein in 2007 after serving as the division chief of Pediatric Infectious Diseases at the former Mount Sinai School of Medicine. In her new role at Montefiore and Einstein, Dr. Herold will be responsible for continuing the expansion and further development of the Division of Pediatric Infectious Diseases’ clinical, translational and basic research efforts, and will oversee the Department’s educational missions. Most recently, Dr. Herold’s lab has concentrated on developing a vaccine for HSV in collaboration with William Jacobs, Jr., Ph.D., professor, Microbiology and Immunology, Einstein. Her lab also directs clinical trials to study strategies designed to protect women and babies from HSV and HIV, and basic and translational studies to determine how the two viruses interact with one another. In addition to her lab research, Dr. Herold also conducts clinical research related to the prevention of infectious disease complications in children who receive organ or bone marrow transplantation.

Similar Private Companies By Industry

Company Name Region
Diamond Phase III Venture LP United States
Canyon Creek Owner LLC United States
World Wide Notary Llc United States
Pacific Packaging Products, Inc. United States
L & H Tool & Die Co. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Albert Einstein College of Medicine, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at